🔎 Trials Near Me

Akèy › Kansè ovè › Kentucky › Louisville

Etid klinik pou Kansè ovè nan Louisville, KY

12 etid pou Kansè ovè ap chèche patisipan nan sit nan ak bò kote Louisville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Ap rekriteFaz 2
  • Site 0251 - Norton Cancer Institute, Louisville
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05128825

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Ap rekriteFaz 3
  • Norton Women's and Children's Hospital, Louisville
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213804

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Ap rekriteFaz 1
  • Norton Cancer Institute, Louisville
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05983432

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Ap rekriteFaz 2
  • Norton Cancer Institute, Louisville
Laj 18 a 99 · Fanm · Mizajou Sep 15, 2026 · NCT07023627

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Ap rekriteFaz 2
  • Norton Cancer Institute, St. Matthews Clinic, Louisville
Laj 18 ak plis · Fanm · Mizajou Sep 14, 2026 · NCT06787612

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

Ap rekriteFaz 1/2
  • Norton Cancer Institute Research, Louisville
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06303505

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Ap rekriteFaz 3
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • Baptist Health Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ap rekrite
  • Norton Hospital Pavilion and Medical Campus, Louisville
  • Baptist Health Louisville, Louisville
  • Norton Suburban Hospital and Medical Campus, Louisville
  • ak 2 plis
Laj 35 a 50 · Fanm · Mizajou Aug 7, 2026 · NCT04251052

EXoPERT EMERALD Clinical Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • KCTL, Louisville
Laj 45 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT07186296

Combination Therapy for Recurrent Ovarian Cancer

Ap rekriteFaz 1/2
  • UofL Health Brown Cancer Center, Louisville
Laj 18 ak plis · Fanm · Mizajou Mar 19, 2026 · NCT05610735

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Baptist Floyd, New Albany · 4 mi lwen
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Etid Kansè ovè nan lòt vil

Lòt etid nan Louisville

Sous ClinicalTrials.gov, done yo ranmase Oct 7, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.